Radionuclide Therapy for the Treatment of Microscopic Ovarian Carcinoma:  An Overview

Radionuclide Therapy for the Treatment of Microscopic Ovarian Carcinoma:  An Overview

Cancer comprises a group of diseases characterized by the uncontrolled growth of abnormal cells that spread from the anatomical site of origin. For many types of cancer, surgery alone has proven inadequate, necessitating a broader approach to treatment incorporating chemotherapy and radiotherapy. Of...

Full description

Saved in:
Bibliographic Details
Published in:Industrial & engineering chemistry research Vol. 39; no. 9; pp. 3135 - 3139
Main Authors: Whitlock, Jenny L, Roeske, John C, Dietz, Mark L, Straus, Chris M, Hines, John J, Horwitz, E. Philip, Reba, Richard C, Rotmensch, Jacob
Format: Journal Article
Language:English
Published: Washington, DC American Chemical Society 01-09-2000
Subjects:
Alpha particles
Biological and medical sciences
Biomedical engineering
Bismuth
Contrast media. Radiopharmaceuticals
Diagnosis
Genital system. Mammary gland
Medical sciences
Oncology
Pharmacology. Drug treatments
Radioisotopes
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Carcinoma
Malignant tumor
Review
Radiotherapy
Physical properties
Female genital diseases
Alpha radiation
Ovarian diseases
Ovary
Ionizing radiation
Treatment
Bismuth
Mechanism of action
Radiopharmaceuticals
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer comprises a group of diseases characterized by the uncontrolled growth of abnormal cells that spread from the anatomical site of origin. For many types of cancer, surgery alone has proven inadequate, necessitating a broader approach to treatment incorporating chemotherapy and radiotherapy. Of particular recent interest has been the use of α-emitters in the treatment of microscopic carcinoma. The effective application of these materials requires an understanding of the physical and biological bases of radiation therapy. In addition, both radiochemical and radionuclidic purity are essential in all clinical applications. Recent work with the α-emitting radionuclide bismuth-212 offers considerable promise in the treatment of microscopic ovarian carcinoma resistant to conventional treatment modalities. Ongoing improvements in methods for its preparation are expected to further improve its therapeutic utility.
Bibliography:ark:/67375/TPS-8SL87TQ0-X
istex:FF8B06873AEB243AA55C38342C3225C6DE17943A
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0888-5885
1520-5045
DOI:10.1021/ie000425u